Insulin degludec is a long-lasting insulin used for type 1 and type 2 diabetes. It is given as a shot under the skin once a day. It works by giving the body a steady, background level of insulin all day and night to keep blood sugar in range.
Every report comes from a Lived member, sent anonymously.
Have you tried Tresiba (Insulin Degludec) for Type 2 Diabetes?
Insulin degludec, sold as Tresiba and also by the same manufacturer under the plain name Insulin Degludec, is a long-acting insulin used to control blood sugar in adults and children 1 year and older with type 1 or type 2 diabetes. It supplies basal (background) insulin, the steady amount the body needs between meals and overnight. In type 1 diabetes, the body makes little or no insulin, so degludec is always paired with a mealtime insulin. In type 2 diabetes, it is often the first insulin a person starts, added to other diabetes medicines when those no longer keep blood sugar in range. In a large two-year study of adults with type 2 diabetes and heart disease, people on degludec had fewer severe low blood sugar episodes than people on insulin glargine, another long-acting insulin, with similar blood sugar control and similar rates of heart attack and stroke. Degludec is not used to treat diabetic ketoacidosis (DKA), a dangerous buildup of acids called ketones that needs fast-acting insulin in a hospital.
Insulin lets muscle and fat take sugar out of the blood and tells the liver to stop releasing more. Even without food, the liver keeps putting sugar into the blood, so the body needs a low, steady level of insulin around the clock. After degludec is injected under the skin, its molecules link into long chains that form a small reservoir. Single molecules break off slowly and enter the bloodstream, where they also cling to a blood protein called albumin, which slows them further. The result is an effect that lasts more than a day, at least 42 hours in studies, with a fairly flat profile and no sharp peak. Because each dose overlaps the last, it takes 3 to 4 days of daily injections to reach a stable level. Degludec does not cover the rise in blood sugar after meals; that is the job of mealtime insulin or other medicines.
Degludec is injected once a day under the skin of the thigh, upper arm or abdomen. It comes in two strengths, U-100 (100 units of insulin per milliliter) and U-200 (200 units per milliliter, for people who need larger doses). U-100 is sold as a FlexTouch pen and as a vial used with a syringe (the vial also suits young children who need very small doses), and U-200 only as a FlexTouch pen. On either pen, the dose window shows the actual number of units, so no conversion is needed. Never draw insulin out of a pen with a syringe, because the strength can be misjudged and cause a serious overdose. Never share a pen, needle or syringe, even after changing the needle, since this can spread blood-borne infections. Adults can inject at any time of day; children should inject at the same time each day. The dose is set for each person and adjusted based on blood sugar readings, usually with at least 3 to 4 days between increases so each change has time to show. People with type 1 diabetes also take mealtime insulin. Degludec is not used in insulin pumps or mixed with other insulins. If an adult misses a dose, they take it when they remember during waking hours, leaving at least 8 hours before the next one. Caregivers of a child who misses a dose should call the prescriber for instructions. Check the label before each injection, since mixing up long-acting and mealtime insulin is a known source of serious errors. Move the injection spot each time within the chosen area. Repeated injections in one spot can cause lumpy or thickened skin that absorbs insulin unpredictably; switching from such a spot to healthy skin can suddenly increase the effect, so check blood sugar more often after a change. Keep unopened pens and vials in the refrigerator and never use insulin that has frozen. Once opened, a pen or vial lasts 56 days (8 weeks) in the refrigerator or at room temperature up to 86°F.
Low blood sugar (hypoglycemia) is the most common side effect. For many people with diabetes this means a reading below 70 mg/dL, though a care team may set a different threshold. Signs include shakiness, sweating, hunger, a fast heartbeat, headache, irritability and confusion. The usual fix is 15 to 20 grams of fast sugar, such as four glucose tablets or half a cup of regular juice, then a recheck after 15 minutes, repeating until blood sugar is back in range. Because degludec acts for so long, recovery from a low can be slower than with shorter-acting insulins, so keep checking and have a snack if the next meal is more than an hour away. Lows are more likely after extra exercise, missed or smaller meals, alcohol, illness, or a dose increase, and they can impair driving. Severe low blood sugar means a person cannot treat themselves, passes out or has a seizure. Someone else should give glucagon (a prescribed nasal spray or injection that raises blood sugar) if available and call 911 right away. Other common effects include modest weight gain (in studies, about 4 pounds on average in type 1 and 6 to 7 pounds in type 2 over a year), redness, itching or bruising at the injection site, rash, and swelling of the hands or feet. A serious allergic reaction is rare; trouble breathing or swelling of the face, tongue or throat needs emergency help.
Many medicines shift blood sugar, so any change in other prescriptions is a reason to check blood sugar more often and ask whether the insulin dose needs adjusting. Other diabetes medicines, including sulfonylureas and GLP-1 (glucagon-like peptide-1) drugs such as semaglutide, add to the risk of lows. Steroid medicines (corticosteroids), some antipsychotics such as olanzapine, thyroid hormone and birth control pills can raise blood sugar and increase insulin needs. Alcohol can push blood sugar either way and is best avoided or discussed with the care team. Beta-blockers, a common class of blood pressure and heart medicines, can hide the shakiness and racing heart that usually signal a low, as can clonidine, another blood pressure medicine. People taking them may need to rely more on blood sugar readings than on symptoms. Taking insulin together with pioglitazone, a diabetes pill in the thiazolidinedione class, can cause fluid retention and lead to or worsen heart failure. Shortness of breath, swelling of the ankles or feet, or sudden weight gain should be reported to the prescriber. Insulin also lowers blood potassium; people on medicines that lower potassium, such as some diuretics (water pills), may need it checked. Pregnancy studies of degludec have not shown an increased risk of birth defects or miscarriage, while poorly controlled diabetes itself carries real risks for parent and baby. Anyone pregnant or planning pregnancy should review their insulin plan with the care team. Switching insulin brands, strengths or types should only happen under medical supervision.
Because degludec builds to a stable level over 3 to 4 days, the full effect of a new dose takes a few days to show. Starting usually involves a period of regular blood sugar checks with a meter or continuous glucose monitor and stepwise dose changes until readings settle in the target range. The long, even action gives some flexibility for adults whose schedules vary, but it also means a dose that is too high keeps lowering blood sugar for more than a day. Insulin needs can change with activity, weight, stress, illness and diet, so doses are reviewed over time rather than fixed. For people with type 1 diabetes, insulin is lifelong. For people with type 2 diabetes, degludec is usually long-term, though the dose or the overall plan may change if weight, other medicines or kidney function change. Regular follow-up visits check blood sugar trends, how often lows happen and whether the regimen still fits daily life.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Tresiba (Insulin Degludec), what you've noticed, or ask the community a question.